Remove tag eu-pharmaceutical-strategy
article thumbnail

Frost & Sullivan's Top 10 predictions for healthcare in 2021

Healthcare IT News - Telehealth

More than 50% of the expected production capacity of the vaccine candidates, which are in Phase III and are getting emergency approval have been pre-booked by developed economies such as the US, EU, Japan, Canada, and the UK. As patients have grown accustomed to digital healthcare, they are now demanding it from their providers.